DSIP
preclinicalAlso known as: Delta Sleep-Inducing Peptide
DSIP (Delta Sleep-Inducing Peptide) was discovered in 1974 and has been studied for sleep disorders, stress, and addiction treatment. While research is not as extensive as newer peptides, it shows consistent sleep architecture improvement with minimal side effects.
Key data
WAGGDASGEMechanism of action
DSIP is an endogenous neuropeptide found in the hypothalamus. Modulates sleep architecture by increasing delta (slow-wave) sleep. Has anxiolytic, stress-protective properties and modulates hypothalamic-pituitary axis hormones.
Frequently asked questions
What is DSIP?
DSIP (Delta Sleep-Inducing Peptide) was discovered in 1974 and has been studied for sleep disorders, stress, and addiction treatment. While research is not as extensive as newer peptides, it shows consistent sleep architecture improvement with minimal side effects.
How does DSIP work?
DSIP is an endogenous neuropeptide found in the hypothalamus. Modulates sleep architecture by increasing delta (slow-wave) sleep. Has anxiolytic, stress-protective properties and modulates hypothalamic-pituitary axis hormones.
What is the research status of DSIP?
DSIP is currently classified as preclinical, with 44 research references on record. This is for research purposes only and is not medical advice.
What is the half-life of DSIP?
The reported half-life of DSIP is Unknown.
What is the molecular weight of DSIP?
DSIP has a molecular weight of approximately 848.86 g/mol.
Related peptides
ACTH analogue — upregulates BDNF/NGF, enhances dopamine/serotonin signaling, neuroprotective.
Tuftsin analogue — stabilizes enkephalins, modulates GABA/serotonin, anxiolytic without sedation.
Build on DSIP data programmatically
Structured peptide data, semantic search, and AI summaries via one API.
Get a free API key